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SUMMARY. The case of 29 years old pregnant III-para at 38 weeks of gestational age is presented. The patient was admit-
ted complaining of vague abdominal pain. By speculum examination the large cervix with reddish ulcerative cervical 
canal was established and punch biopsy performed. The pathohistological diagnosis was well differentiated squamous 
cell carcinoma. No local metastases or lymph node or other signs of cancer spreading were present (stage 1a). The CS 
was done, born vital newborn of 2 kg weight, proceeded to total abdominal hysterectomy with bilateral salpingoopho-
rectomy. The pathohistological finding was: Stromal invasion of 3 mm in depth and 6 mm in lateral spread (FIGO stage 
1a1). Postoperative period was uneventfull, the patient was reffered to Institute of Nuclear Medicine for further manage-
ment, where she received only 2 cycles of radiation and chemotherapy and thereafter stopped the treatement. Two years 
later the patient presented very ill and passed because of uremia.
Prikaz bolesnice
Klju~ne rije~i: trudno}a, karcinom, karcinom cerviksa
SA`ETAK. Prikazana je bolesnica dobi 29 godina, III-para, s oko 38 tjedana trudno}e. Primljena je zbog nejasnih boli u 
donjem trbuhu. Pregledom u spekulima na|en je krupni cerviks s ulceracijom u cervikalnom kanalu. Pod anestezijom je 
u~injena biopsija cerviksa i dobivena patohistolo{ka dijagnoza: dobro diferencirani karcinom plo~astih stanica. Nije bilo 
lokalnih metastaza, {irenja u limfne ~vorove ili drugih znakova {irenja raka (stupanj 1a). U~injen je carski rez i nastav-
ljena totalna histerektomija s obostranom salpingooforektomijom. Patohistolo{ki nalaz je bio: stomalna invazija 3 mm u 
dubinu i postrani~na zahva}enost 6 mm (FIGO stupanj 1a1). Postoperativni je tijek bio uredan, bolesnica je upu}ena u 
Zavod za nuklearnu medicinu radi zra~enja i kemoterapije. Primila je samo dva ciklusa terapije i tada napustila lije~enje. 
Nakon dvije godine pacijentica se pojavila vrlo bolesna, umrla je od uremije.
Introduction
Cervical cancer is widely quoted to be one of the im-
portant malignancy in pregnancy. However the epidemi-
ology of both cervical cancer and pregnancy are chang-
ing. In most western countries with organized screening 
the incidence of cervical cancer has dropped dramati-
cally in the last 20 years. There has also been a signifi-
cant stage shift to earlier stage disease: for many women 
of childbearing age the diagnosis represents micro inva-
sive cancer. This is associated with an excellent progno-
sis and can be managed without major impact on current 
or future pregnancy.1 Coincident with the change in cer-
vical cancer incidence, the mean age at child birth in 
most western countries has increased to over 30, and 
increasing age is associated with increasing frequency 
of many cancers. A study linking California Cancer 
Registry data with maternal hospital discharge records 
for 1991–1999 reported a diagnosis of all malignancies 
in association with 1/1000 childbirths. Breast and thy-
roid cancers were more common than the cervix one.2
Clearly the situation is likely to be different in devel-
oping countries.
One to 3 percent of women diagnosed with cervical 
cancer are pregnant or postpartum at the time of diagno-
sis.3,4 About one-half of these cases are diagnosed pre-
natally and the other half are diagnosed within 12 months 
following delivery.5 Cervical cancer is one of the most 
common malignancies in pregnancy, with an estimated 
incidence of 0.8 to 1.5 cases per 10 000 births.5,8
Most patients are diagnosed at an early stage of dis-
ease.9,10 This is probably a result of routine prenatal 
screening, but it is also possible that advanced stage dis-
ease interfers with conception. Stage for stage, the 
course of disease, and prognosis of cervical cancer in 
pregnant patients are similar to those of non-pregnant 
patients.10,11
There are no data from large randomized trials upon 
which to base recommendations for the care of pregnant 
patients with cervical cancer. Therefore, management is 
based upon evidence from randomized trials in non-
pregnant women, findings from observational studies of 
pregnant women, and the unique medical and ethical 
considerations underlying each individual case. Treat-
ment should be individualized and based on the stage of 
cancer, the woman’s desire to continue pregnancy, and 
the risks of modifying or delaying therapy during preg-
nancy.
The presenting symptoms and signs of cervical carci-
noma in pregnancy are dependent upon the clinical 
stage and lesion size. In two series, all pregnant patients 
with stage IA and 50 percent of those with stage IB car-
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cinoma were asymptomatic at the time of diagnosis.8,12 
Patients with symptomatic stage IB disease presented 
with abnormal vaginal bleeding or discharge; clinical 
manifestations in patients with more advanced disease 
also included pelvic pain, sciatica-type leg pain, flank 
pain, chronic anemia, and shortness of breath.
The diagnosis of cervical cancer is often delayed in 
pregnant women since many of these symptoms are sim-
ilar to those associated with a normal pregnancy. In one 
study, the average duration of symptoms before diagnosis 
of cervical cancer in pregnancy was 4.5 months.13
Herewith we report a rare case of cervical carcinoma.
Case report
Female 29 years old, married for six years, illiterate, 
from western Sudan, presented to outpatient clinic in 
Wad Medani Maternity Hospital complaining of vague 
abdominal pain. Admitted as first stage of labour, later 
proved not to be in labour. We reviewed her medical his-
tory and performed an ultrasound examination of the 
fetus and of the cervix. Her previous two pregnancies 
she delivered vaginally at term and had been uncompli-
cated. She had no ongoing medical problems. The cur-
rent baby was normally grown and no gross physical 
abnormalities were seen within the limits of an anatom-
ical survey for this gestational age. The cervix measured 
40 mm in length; no obvious adnexal abnormalities 
were seen, appreciated gestational age was 38 weeks.
Per vagina examination and cervical assessment 
showed no apparent vaginal bleeding or discharge, va-
gina healthy and moist, vulva normal. Cervix central, 
firm, nodular, hard, long (2 cm), and the os was closed. 
This finding encouraged us to speculum examination 
which confirmed the above findings; the large cervix 
with reddish ulcerative cervical canal and not bleed in 
touch was found.
Examination under anaesthesia was done and showed 
that parametrium and Douglas’ pouch were free. No lo-
cal metastases in the vagina or inguinal lymph nodes 
(stage 1a). Per rectum examination showed that the 
sphincters are intact, normal mucosa and there are no 
features of local spread. Punch biopsy was taken for his-
topathology. The result was »the well differentiated 
squamous cell carcinoma.« General investigations show-
ed no abnormality except low haemoglobin value (9 
gm/dl).
Her management supervised by a team consisting 
from obstetrician gynaecologist, haematologist, and hi-
stopathologist. Cesarean section was done, proceeding 
to total abdominal hysterectomy and bilateral salping-
oophorectomy. We did an upper segment uterine inci-
sion to avoid the tumor. A 2 kg viable nice baby was 
delivered, cried immediately.Apgar score in 1, 5, 10 
minutes were within normal. Intra-operative findings 
showed that there were no parametrium, bladder, utero-
sacral ligament involvements. There was no ascites and 
no lymph nodes involvement. Vaginal stump was closed 
by purse string. Haemostasis easy secured. Estimated 
blood loss was 800 ml.The postoperative period passed 
smoothly, and the patient was discharged with her baby 
on 10th postoperative day in good health. The histopa-
thology report staged the cervical cancer as FIGO stage 
(1a1): »Stromal invasion measured 3 mm in depth and 
6 mm in lateral spread.« Ovaries, tubes and uterus were 
unremarkable.
The patient was referred to Institute of Nuclear Med-
icine and Oncology for further management, where she 
received 2 cycle of radiation and chemotherapy. Unfor-
tunately she stopped the treatment.
Two years later she presented to us very ill, uraemic, 
with acute renal failure and uropathy. She passed be-
cause of uraemia and her baby playing around her.
Discussion
Invasive cervical cancer during pregnancy is rare but 
is a dilemma for women and their physicians. The pres-
ent study and review of the literature suggest that preg-
nancy does not seem to influence the prognosis of cer-
vical cancer. Delayed treatment could be proposed to 
selected patients diagnosed at the end of the second tri-
mester or at the beginning of the third trimester, with a 
small tumor (<2 cm) and negative nodes, after a multi-
disciplinary approach.
In his issue Germann et al.14 describe a series of 21 
cases of cervical cancer managed during pregnancy or 
the postpartum period. They point out that, despite nu-
merous publications, questions remain regarding cervi-
cal cancer in pregnancy. What is the impact of pregnan-
cy on the stage at diagnosis? Does pregnancy adversely 
affect prognosis? What is the consequence of planned 
delay of treatment so the pregnancy can be continued to 
a viable gestation? What is the most appropriate treat-
ment?
Regarding stage at diagnosis, it is noted that in this 
study microinvasive disease is excluded, and yet still 
71% were stage I; 76% were asymptomatic but it is not 
reported how many cases were diagnosed by smear. 
Pregnancy offers an opportunity for cervical screening 
but also brings challenges for early diagnosis. Colpos-
copy is technically more difficult, the complication rate 
following biopsy is higher, and further, vaginal bleeding 
caused by cervical cancer may go undiagnosed due to 
assumptions about pregnancy related causes. However, 
although some women may have a delayed diagnosis in 
pregnancy, the data in this paper and previous reports 
would generally suggest that stage is not affected ad-
versely by pregnancy and may even be improved.15
Should invasive carcinoma be discovered in early 
pregnancy and thought to be unsuitable for primary sur-
gical therapy, termination of the pregnancy is usually 
carried out with the method depending on the gestation-
al age and is followed by radiotherapy. Certain patients 
with early stages of disease may be treated primarily 
with radical hysterectomy and pelvic lymphadenecto-
95
Gynaecol Perinatol 2009;18(2):93–95 Elhassan E. M. et al. Cervical carcinoma in pregnancy: case report
my. In contrast, our patient was treated by abdominal 
total hysterectomy and bilateral salpingoopherectomy 
dictated by our trend since the involvement of pelvic 
lymph nodes is expected to be rare (1%).16 If the carci-
noma is discovered in the later weeks of pregnancy, a 
delay in treatment is considered permissible to allow for 
viability of the fetus. For those patients diagnosed in the 
latter stage of pregnancy with a viable fetus, delivery by 
caesarean section is usually recommended although 
studies have not shown that vaginal delivery has pro-
duced a higher morbidity or decreased survival in pa-
tients delivered by this way.
In summary, cervical cancer remains an important but 
rare condition in pregnancy. The key to further limita-
tion of mortality and morbidity from this condition is 
cervical screening. However, cases will still occur. Cur-
rent data suggest that pregnancy does not adversely af-
fect stage at diagnosis or prognosis. However, even with 
the further cases added in this issue, there are inade-
quate data to advise women from an evidence base on 
whether delay of treatment to facilitate delivery is safe, 
and there are almost no data upon which to base advice 
to women with disease beyond stage 1b. Treatment 
should be multidisciplinary and individualised follow-
ing careful counseling. Further understanding of the 
natural history of cervical cancer is required. The col-
laborative collection of data relating to treatment and 
outcome, as advocated by the authors, is strongly en-
couraged.
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